Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Inhale acquires Bradford Particle Design for $200mm

Executive Summary

Leveraging its technological strength in powders and inhalation, and seeking to broaden its product base, Inhale Therapeutic Systems is acquiring UK company Bradford Particle Design (engineers particles for drug delivery) for about $210mm---$190mm in stock (about 3.75mm shares) and $20mm in cash, or about 23 times its 2000 sales.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies